Philipp Harter
Philipps University of Marburg(DE)Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe(DE)Kliniken Essen-Mitte(DE)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Intraperitoneal and Appendiceal Malignancies
Most-Cited Works
- → Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer(2019)1,962 cited
- → Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer(2012)1,873 cited
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials(2009)1,581 cited
- → Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial(2014)1,433 cited
- → Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk